Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-10

PCSK9 Inhibitor with Statin Therapy for Intracranial Artery Stenosis ( PISTIAS): Rationale and design of a multicenter randomized controlled trial

Xinzhi Hu, Zongmuyu Zhang, Caiyan Liu [...]

International Journal of Stroke

Open access

Research article

First published 2017

A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics

Jeffrey E Ming, Ruth E Abrams, Derek W Bartlett [...]

Gene Regulation and Systems Biology

Free access

Review article

First published 2021-2

Lipid-lowering therapies in peripheral artery disease: A review

Nedaa Skeik, Meagan E Nowariak, Jenna E Smith [...]

Vascular Medicine

Open access

Research article

First published 2019-1

Real-world use of PCSK9 inhibitors: A single-center experience

Sinan Sarsam, Abeer Berry, George Degheim [...]

Journal of International Medical Research

Open access

Review article

First published 2025

What is the impact of lipid-lowering therapies on cardiovascular disease incidence among women with familial hypercholesterolaemia: A systematic review

Catherine Hennessy, Declan Patton, Tom O’Connor [...]

Women's Health

Open access

Review article

First published 2021

Neurocognitive effects associated with proprotein convertase subtilisin-kexin type 9 inhibitor use: a narrative review

Wei C. Yuet, Didi Ebert, Michael Jann

Therapeutic Advances in Drug Safety

Free access

Research article

First published 2018-7

The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia

C. Michael White

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Review article

First published 2025-7

PCSK9 in peripheral arterial disease: Mechanisms and therapeutic perspectives

Yue Gao, Jing Zhang, Nan Jiang [...]

Science Progress

Retricted access

Review article

First published 2018-10

The Role of PCSK9 Inhibitors in the Treatment of Hypercholesterolemia

Roshni S. Patel, Emily M. Scopelliti, Oludamilola Olugbile

Annals of Pharmacotherapy

Open access

Review article

First published 2020

The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease

Eun Ji Kim, Anthony S. Wierzbicki

Sage Open Chronic Disease

Search results